Profit

Regulatory Environment Unfavourable For Pharma Companies: Surjit Pal

PUBLISHED ON: May 23, 2017 | Duration: 9 min, 10 sec

  
loading..
Surjit Pal, pharma analyst at Prabhudas Lilladher, says given price competition, competitive horizon in US and regulatory interferences indicate the overall scenario is not supportive for generic Prabhudas Lilladher players.
ALSO WATCH
Cannes Lions 2017: Prasoon Joshi Talks About Grand Prix Winning Campaign

................................ Advertisement ................................

................................ Advertisement ................................